Keyphrases
In(III)
100%
Head-and-neck Cancer
100%
Comprehensive Assessment
100%
Oral Cavity
60%
P16INK4a
60%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
60%
HPV DNA
60%
HPV6
60%
South America
40%
Europe
20%
Immunohistochemistry
20%
Cyclin D1 (CCND1)
20%
Quality Control
20%
Cell Transformation
20%
High-risk Human Papillomavirus (HR-HPV)
20%
Cancer Tissue
20%
Most Common Form
20%
HPV16
20%
Highly Heterogeneous
20%
Northern Europe
20%
Oropharynx
20%
Histopathological Examination
20%
Formalin-fixed Paraffin-embedded Tissue
20%
Cancer Site
20%
Central and Eastern Europe
20%
Pharynx
20%
Viral Detection
20%
Southern Europe
20%
HPV-related Cancers
20%
Southeastern Europe
20%
Laryngeal Cancer
20%
South-Central Europe
20%
Pathology Archives
20%
HPV Testing
20%
RNA Detection
20%
DNA Quality
20%
Medicine and Dentistry
Biological Marker
100%
Head and Neck Cancer
100%
Oral Cavity
60%
Messenger RNA
60%
P16
60%
Larynx
60%
Oropharynx
60%
Malignant Neoplasm
40%
Cancer Tissue
20%
Protein P53
20%
Immunohistochemistry
20%
Formaldehyde
20%
Cell Transformation
20%
Wart Virus
20%
Human Papillomavirus Type 16
20%
Cyclin D1
20%
Cancer Localization
20%
Pharynx
20%
Oropharynx Carcinoma
20%
Laryngeal Cancer
20%
Virus Detection
20%
Biochemistry, Genetics and Molecular Biology
Messenger RNA
100%
P16
100%
Oropharynx
100%
Transcription
33%
Cell Transformation
33%
P53
33%
Cyclin D1
33%
Quality Control
33%
Wart Virus
33%
Human Papillomavirus Type 16
33%
Virus Detection
33%
Pharynx
33%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Head and Neck Cancer
100%
Malignant Neoplasm
80%
Messenger RNA
60%
Protein P53
20%
Cyclin D1
20%
Formaldehyde
20%
Human Papillomavirus
20%
Human Papillomavirus Type 16
20%
Oropharynx Cancer
20%
Oropharynx Carcinoma
20%
Larynx Cancer
20%
Immunology and Microbiology
Neck
100%
Oropharynx
60%
Cell Transformation
20%
P53
20%
Wart Virus
20%
Cancer Tissue
20%
Human Papillomavirus Type 16
20%
Cyclin D1
20%
Virus Detection
20%